SCHEMBL8707295

SCHEMBL8707295

CC(C)(C)OC(=O)N1CCCC(COc2ccccc2CCc2cccc(OC(F)F)c2)C1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.47
HTR6 P50406 7/20 0.46
BCHE P06276 4/20 0.45
ALOX5AP P20292 1/20 0.44
FEN1 P39748 1/20 0.44
CHEK2 O96017 1/20 0.42
ACKR3 P25106 1/20 0.41
USP30 Q70CQ3 1/20 0.41
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HSD17B10 Q99714 1/20 0.41
SLC2A1 P11166 1/20 0.40
PFKFB3 Q16875 1/20 0.40
KDM1A O60341 1/20 0.40
HCRTR1 O43613 1/20 0.40
HCRTR2 O43614 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8702698 0.92 TP53 (0.49) SCN9AHTR6BCHETP53CYP3A4
SCHEMBL8709905 0.92 TP53 (0.49) SCN9AHTR6BCHETP53CYP3A4
SCHEMBL8702705 0.92 TP53 (0.49) SCN9AHTR6BCHETP53CYP3A4
SCHEMBL8702097 0.87 HTR6 (0.47) SCN9AHTR6BCHEACKR3TP53
SCHEMBL9068236 0.87 SLC2A1 (0.51) TP53CYP3A4ALOX15TSHRMAPK1
SCHEMBL9068232 0.87 SLC2A1 (0.51) TP53CYP3A4ALOX15TSHRMAPK1
SCHEMBL8703510 0.84 ABCB1 (0.50) TP53CYP3A4ALOX15TSHRMAPK1
Hydrochloric Acid SCHEMBL8703538 0.84 ABCB1 (0.49) TP53CYP3A4ALOX15TSHRMAPK1
SCHEMBL27523517 0.83 SCN9A (0.51) SCN9AHTR6BCHEALOX5APFEN1
SCHEMBL27341185 0.83 SCN9A (0.51) SCN9AHTR6BCHEALOX5APFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1044365-C Alpha, omega-diarylalkane derivatives, their preparation and their use in the treatment and prevention of circulatory diseases and psychosis SANKYO CO (JP) 1999-07-28 CN disclosed
EP-0844000-A1 Use of alpha, omega-diarylalkane derivatives in the treatment and prevention of psychosis SANKYO COMPANY LIMITED (JP) 1998-05-27 EP disclosed
US-5556864-A TREATMENT OF CIRCULATORY DISEASES AND PSYCHOSIS SANKYO COMPANY, LIMITED (JP) 1996-09-17 US disclosed
CN-1102640-A Alpha, omega-diarylalkane derivatives, their preparation and their use in the treatment and prevention of circulatory and psychiatric disorders SANKYO CO (JP) 1995-05-17 CN disclosed
EP-0600717-A1 Phenoxyalkylamines, -pyrrolidines and -piperidines for the treatment and prevention of circulatory diseases and psychosis SANKYO COMPANY LIMITED (JP) 1994-06-08 EP disclosed